Global Progressive Supranuclear Palsy Therapeutics Market 2019-2023

Some of the key findings from our progressive supranuclear palsy therapeutics market forecast report are summarized below

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global progressive supranuclear palsy therapeutics industry overview

As progressive supranuclear palsy is rare and affects a limited patient group, a majority of the global population is unaware of the disease. This has induced organizations across the world to conduct awareness programs to educate people about the disease. Several organizations are providing funds for researchers researching the treatment of rare neurodegenerative disorders such as progressive supranuclear palsy. Many vendors across the globe are also conducting awareness campaigns to educate people regarding the diagnosis of the disease. This will result in increased awareness and the early diagnosis of the disease, which will be a significant factor driving the growth of the market during the forecast period.

The unmet need for the treatment of progressive supranuclear palsy has encouraged various pharmaceutical vendors, research institutes, and biotechnology firms to develop novel therapies for treatment. This has resulted in the presence of a strong pipeline of early and mid-stage therapies for the treatment of progressive supranuclear palsy. Though market might not witness the approvals for the early-stage therapies over the forecast period, advancements in research will result in the entry of more vendors. This will subsequently attract investors who will fund several pharmaceutical companies. As a result of such factors, the market will register a CAGR of almost 5% during the forecast period.

Top progressive supranuclear palsy therapeutic companies covered in this market research report

The global progressive supranuclear palsy therapeutics market is highly concentrated. To help clients improve their revenue, this report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Key insights provided by this progressive supranuclear palsy therapeutics market analysis report will helps clients create strategies to make the most of future growth opportunities.

The report offers a detailed analysis of several companies, including:

• AbbVie Inc.
• Acorda Therapeutics Inc.
• Biogen Inc.
• Bristol-Myers Squibb Co.
• Merck & Co. Inc.

Progressive supranuclear palsy therapeutics market segmentation based on product

• Dopamine
• Anticholinergic agents
• Tricyclic antidepressants
• Others

The dopamine segment will account for the largest global supranuclear palsy therapeutics market share. Dopamine drugs such as carbidopa-levodopa are the most-effective treatment option for the motor symptoms of progressive supranuclear palsy in the early stages. Dopamine agonists are also used as the first line of treatment to avoid the side effects associated with the treatment using carbidopa-levodopa. The lack of approved novel therapies for the treatment of progressive supranuclear palsy is expected to drive the growth of the market in this product segment.

Progressive supranuclear palsy therapeutics market segmentation based on geography

• Asia
• Europe
• North America
• ROW

North America is the largest market for progressive supranuclear palsy therapeutics market. The increasing number of awareness programs by various organizations in the region towards educating the general population about the disease and the advancements in drug research will influence region’s contribution to the progressive supranuclear palsy therapeutics market size in North America.

Key highlights of the global progressive supranuclear palsy therapeutics market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the progressive supranuclear palsy therapeutics market during the next five years
• Precise estimation of the global progressive supranuclear palsy therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the progressive supranuclear palsy therapeutics industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details of factors that will challenge the growth of progressive supranuclear palsy therapeutics companies  

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch